A complete application in a minute
Tailored resume and cover letter, ready to send.
Dalea is building a data management platform for biology and lab workflows. We are hiring a production infrastructure and security lead to own the underlying platform running on Docker Compose and Kubernetes, with a strong focus on GxP compliance and data integrity.
You will work hands-on to secure and scale the system, implement ISO 27001/SOC 2 controls, and support regulated software validation for customers in biotech and pharma. This is a full-time, on-site role in Copenhagen.
Keep a Part 11 and Annex 11 compliant lab data platform secure, reliable and trusted, and own the infrastructure it runs on.
We ask pharma and biotech teams to trust a young company with their most valuable research data. That's a big decision, and they're right to be careful. Dalea already has the safeguards. You'll keep them strong, improve them, and make them easy to verify.
You don't need deep frontend skills, lab or biology knowledge, a PhD or Danish. If you match the must-haves, apply, even if you have none of the nice-to-haves.
TypeScript, Next.js and React. Python for our MCP service. An agent harness built on Mastra. Docker Compose and Kubernetes, hosted on Scaleway.
Our dev team is the two founders plus up to three new developers, led by our CTO. We discuss progress and priorities closely and continuously, and we expect you to take part: share ideas early, argue for what you think is right, and change course when the evidence says so.
You won't need permission to fix what's broken, and what you build reaches production quickly. We work together at BioInnovation Institute 3–5 days a week. We're building the team and the way we work, and that happens best in person.
Dalea is a data management platform for biology and lab workflows. Experiments, structured data, samples and inventory sit in one place, with full data provenance. Everything a lab builds in Dalea can be packaged and shared, so we're building a GitHub for life science: labs publish and reuse each other's workflows instead of rebuilding them from scratch. We work with biotech startups, academic labs, pharma R&D and CROs.
This position depends on our current funding round closing, which we expect in February/March 2027. We can make a conditional offer before then, and we'll be open with you about the timing throughout the process.